Advarra Executive Michele Russell-Einhorn Featured in BBK Worldwide COVID-19 Response
BBK Worldwide featured Michele Russell-Einhorn, Advarra Chief Compliance Officer and Institutional Official, in their latest communication addressing the research industry’s patient-centric response to COVID-19.
In the publication, BBK Worldwide discusses how the industry’s reaction to COVID-19 has proven the importance of patient partnerships, highlighting ways research professionals have broken down enrollment barriers and supported current research participants during the crisis.
“[We have] seen the rise of a cooperative partnership among public, private, and government resources as we all participate in the shared urgent drive to find ways to prevent, treat, and diagnose this disease,” says Michele Russell-Einhorn, Advarra Chief Compliance Officer and Institutional Official.
BBK Worldwide is a full-service R&D marketing firm committed to enhancing the clinical trial participant experience through a combination of services and technology-driven solutions that educate consumers, engage participants, unburden sites, and support sponsors.
Advarra is committed to supporting the research community through the current crisis and has policies and processes in place to keep all operations functioning as normal. Contact Advarra for dedicated research compliance support during the COVID-19 pandemic. For more on the research impact of COVID-19, visit Advarra’s Coronavirus Guidance webpage.